Optiscan Imaging Limited

Equities

OIL

AU000000OIL4

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 06:43:35 03/06/2024 BST			5-day change	1st Jan Change
0.12 ^AUD	+4.35%		+14.29%	+42.86%

05-13	Optiscan Imaging Limited Signs Know-How Agreement with Mayo Clinic	CI
05-13	Optiscan Imaging CEO to Host Mayo Clinic Agreement Webinar	MT

Optiscan Imaging Limited Announces Resignation of Archie Fraser as CEO

January 22, 2018 at 04:31 am

Optiscan Imaging Limited announced that Mr. Archie Fraser has resigned from the company effective January 22, 2018. Optiscan has commenced the process of recruitment of a suitably experienced and qualified CEO to lead this company forward as the company enter this next exciting and significant period in the lifespan of the company.

Latest news about Optiscan Imaging Limited

Optiscan Imaging Limited Signs Know-How Agreement with Mayo Clinic	05-13	CI
Optiscan Imaging CEO to Host Mayo Clinic Agreement Webinar	05-13	MT
Optiscan Imaging Receives More Than AU$670,000 as R&D Tax Rebate	03-21	MT
Optiscan Imaging Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-22	CI
Optiscan Imaging Secures AU$3 Million Research Grant for Endomicroscope Device; Shares Rise 8%	02-13	MT
Optiscan Imaging Appoints COO	23/10/23	MT
Optiscan Imaging Limited Appoints Brendan Fafiani to the Role of Chief Operating Officer, Effective 6 November 2023	23/10/23	CI
Cancer Images from Optiscan's Platform Comparable With Conventional Histology Analysis, Study Says	20/09/23	MT
Optiscan Imaging Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/08/23	CI
Optiscan Imaging Completes Key Milestone for Telepathology Project	15/08/23	MT
Optiscan Imaging Establishes New Commercial Operation in the US	03/04/23	MT
Optiscan Imaging Confirms High Diagnostic Rate of Imaging Device	14/03/23	MT
Optiscan Imaging Receives US FDA Feedback for Oral Imaging Product	02/03/23	MT
Optiscan Imaging Limited Intends to Pursue De Novo Pathway for InVivage	02/03/23	CI
Optiscan Imaging Limited Reports Earnings Results for the Half Year Ended December 31, 2022	27/02/23	CI
Optiscan Imaging Limited Announces Partnership with Prolucid Technologies to Develop AI Algorithms	29/01/23	CI
Optiscan Imaging Proposes Issuance of 6 Million Securities	25/10/22	MT
Optiscan Imaging Acquiring Clinical Datasets from Managing Director; Shares Rise 4%	25/10/22	MT
Optiscan Imaging Secures R&D Tax Rebate	24/10/22	MT
Optiscan Imaging Limited Reports Earnings Results for the Full Year Ended June 30, 2022	31/08/22	CI
Optiscan Imaging Files US FDA Application for Oral Tissue Imaging Device	22/08/22	MT
Optiscan Submits FDA 510(k) Application for InVivage Device	22/08/22	CI
Optiscan Imaging Limited Announces Strategic Distribution Partnership - Additional Information	28/06/22	CI
Optiscan Imaging Appoints China Distributor for Research, Preclinical Device	27/06/22	MT
Optiscan Imaging Limited Announces Strategic Distribution Partner for China	26/06/22	CI

Chart Optiscan Imaging Limited

Duration

Period

More charts

Company Profile

Optiscan Imaging Limited is an Australia-based company, which is engaged in the development, manufacturing and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. The Companyâs technology enables real-time, non-destructive, three-dimensional (3D), in-vivo imaging at the single-cell level. It provides real-time microscopic imaging tools to healthcare providers and researchers to enable the early detection and management of disease. Its InVivage device is an intra-oral digital microscope that offers the power of single-cell oral imaging at your fingertips in the palm of your hand. Its ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand.

Sector

Advanced Medical Equipment & Technology

Calendar

28/08/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
OPTISCAN IMAGING LIMITED	+42.86%	63.78M
THERMO FISHER SCIENTIFIC	+7.01%	217B
DANAHER CORPORATION	+11.01%	190B
INTUITIVE SURGICAL, INC.	+19.20%	143B
BOSTON SCIENTIFIC CORPORATION	+30.79%	111B
SIEMENS HEALTHINEERS AG	+1.22%	64.59B
EDWARDS LIFESCIENCES CORPORATION	+13.95%	52.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.16%	48.45B
AGILENT TECHNOLOGIES, INC.	-6.20%	38.03B
GE HEALTHCARE TECHNOLOGIES INC.	+0.91%	35.6B

Other Advanced Medical Equipment & Technology